Molecular Docking, Pharmacokinetics and Molecular Dynamics Simulation Studies of Some Bioactive Compounds Isolated from Entandrophragma congoënse for Antiplasmodial Activity

Ahmed, Sikiru Akinyeye and Happi, Gervais Mouthé and Soh, Désiré and Salau, Shina (2022) Molecular Docking, Pharmacokinetics and Molecular Dynamics Simulation Studies of Some Bioactive Compounds Isolated from Entandrophragma congoënse for Antiplasmodial Activity. Asian Journal of Chemical Sciences, 12 (2). pp. 1-13. ISSN 2456-7795

[thumbnail of 209-Article Text-375-1-10-20220924.pdf] Text
209-Article Text-375-1-10-20220924.pdf - Published Version

Download (1MB)

Abstract

As a follow-up to earlier reported works on the phytochemical study of some isolated bioactive compounds from the root and bark of Entandrophragma congoënse as potent anti-plasmodium drugs (Happi et. al.2005), some of the isolated compounds were tested in vitro for antiplasmodial and cytotoxicity but no insight was given into the binding affinities of these compounds, the ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), drug-likeness studies as well as molecular dynamics simulation of some of the isolates. Hence, a total of 21 compounds including 19 isolates and 2 standard drugs were computationally studied for antimalarial activity against the target receptor with Protein Data Bank code (PDB code: 5TBO), but only 4 of the isolated compounds (L1, L2, L4 and L15) showed promise potent hits against Plasmodium. The results of molecular docking, ADMET studies and molecular dynamics simulations reveal that compound L15, when isolated, can alone, or together with other qualified compounds such as L1, L2 and L4 provide a better inhibition rating compared to Chloroquine® (L21) the FDA-approved drug for the treatment of malaria.

Item Type: Article
Subjects: European Repository > Chemical Science
Depositing User: Managing Editor
Date Deposited: 04 Feb 2023 04:22
Last Modified: 02 Mar 2024 04:10
URI: http://go7publish.com/id/eprint/1527

Actions (login required)

View Item
View Item